[Elsevier] 62305 IHS4-100 responses and other IHS4 outcomes with the IL-17A- and IL-17F-inhibiting Nanobody sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS): Week 24 results from the Phase 2 MIRA trial |
|
This post will be closed automatically in 2026-08-28 23:36
Reward20points
|
| |
10
Sustainability of waste-to-hydrogen conversion pathways: A life cycle thinking-based assessment
10
Natural convection onset during melting of phase change materials: Part I 每 Effects of the geometry, Stefan number, and degree of subcooling
10
Asymmetric PCM melting and thermal convection in a rectangular enclosure with straight and wavy heat transfer passages
20
62305 IHS4-100 responses and other IHS4 outcomes with the IL-17A- and IL-17F-inhibiting Nanobody sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS): Week 24 results from the Phase 2 MIRA trial
10
Unleashing ZIF-8 mediated magnetic nanocatalyst for biodiesel synthesis: Optimization, thermo-kinetics, cost estimation, and green parametric analysis
